Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Med Chem ; 12(2): 173-90, 2005.
Article in English | MEDLINE | ID: mdl-15638734

ABSTRACT

Quassinoids are highly oxygenated triterpenes, which were isolated as bitter principles from the plants of Simaroubaceae family. Their synthesis has attracted much attention because of the wide spectrum of their biological properties. The most prevalent quassinoids have C-20 picrasane skeleton, some known as bruceolides as they were isolated from the genus Brucea, which showed marked antileukemic and antimalarial activities.


Subject(s)
Drug Design , Plants, Medicinal/chemistry , Quassins , Animals , Antimalarials/chemistry , Antimalarials/isolation & purification , Antimalarials/pharmacology , Antineoplastic Agents/chemistry , Antineoplastic Agents/isolation & purification , Antineoplastic Agents/pharmacology , Brucea/chemistry , Quantitative Structure-Activity Relationship , Quassins/chemistry , Quassins/isolation & purification , Quassins/pharmacology , Triterpenes/chemistry , Triterpenes/isolation & purification , Triterpenes/pharmacology
2.
Med Chem ; 1(1): 3-11, 2005 Jan.
Article in English | MEDLINE | ID: mdl-16789880

ABSTRACT

Bruceantin (1), a classical quassinoid with the highest reported antimalarial activity among the quassinoids examined thus far, was selected as a natural product lead for the design of a series of A/B-ring analogs. A viable strategy for the synthesis of the series was developed. The functionalized A-ring and the C-15 ester moiety in bruceantin are incorporated in all designed compounds. The preliminary bioassay results will be discussed in detail.


Subject(s)
Antimalarials/chemistry , Antimalarials/pharmacology , Drug Design , Quassins/chemistry , Quassins/pharmacology , Animals , Antimalarials/chemical synthesis , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Drug Screening Assays, Antitumor , Humans , Molecular Structure , Parasitic Sensitivity Tests , Plasmodium falciparum/drug effects , Quassins/chemical synthesis , Structure-Activity Relationship
3.
Curr Med Chem ; 9(17): 1631-53, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12171558

ABSTRACT

A variety of hydroxamic acid derivatives have recently been touted for their potential use as inhibitors of hypertension, tumor growth, inflammation, infectious agents, asthma, arthritis, and more. Here we provide a comprehensive review of the basic medicinal chemistry and pharmacology of hydroxamic acid derivatives that have been examined as inhibitors of zinc metalloproteases, matrix metalloproteinases, leukotriene A(4) hydrolases, ureases, lipoxigenases, cyclooxygenases, as well as peptide deformilases.


Subject(s)
Amidohydrolases , Hydroxamic Acids/chemistry , Hydroxamic Acids/pharmacology , Aminopeptidases/antagonists & inhibitors , Angiotensin-Converting Enzyme Inhibitors/chemistry , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Animals , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Enzyme Inhibitors/therapeutic use , Epoxide Hydrolases/antagonists & inhibitors , Humans , Hydroxamic Acids/therapeutic use , Inhibitory Concentration 50 , Metalloendopeptidases/antagonists & inhibitors , Structure-Activity Relationship
4.
J Nat Prod ; 59(1): 73-6, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8984156

ABSTRACT

A new quassinoid, 11-O-trans-p-coumaroyl amarolide (1) was isolated from Castela texana, and the structure was elucidated by spectroscopic analysis. Compound 1 is the first coumaroyl quassinoid derivative to have been isolated from nature. The known compounds amarolide (2), chaparrinone, chaparrin, glaucarubolone, holacanthone, and 15-O-beta-D-glucopyranosyl glaucarubol were also isolated. All isolated compounds were tested for their cytotoxicity and antiprotozoal activities.


Subject(s)
Antineoplastic Agents, Phytogenic/isolation & purification , Antiprotozoal Agents/isolation & purification , Plants, Medicinal/chemistry , Triterpenes/isolation & purification , Animals , Antimalarials/pharmacology , Antineoplastic Agents, Phytogenic/pharmacology , Antiprotozoal Agents/pharmacology , Giardia/drug effects , Mexico , Plasmodium falciparum/drug effects , Texas , Triterpenes/pharmacology , Trypanocidal Agents/pharmacology , Tumor Cells, Cultured
5.
J Med Chem ; 38(9): 1437-45, 1995 Apr 28.
Article in English | MEDLINE | ID: mdl-7739002

ABSTRACT

The terpenoid 6,7-diformyl-3',4',4a',5',6',7',8',8a'-octahydro-4,6',7'-trihydrox y-2',5',5', 8a'-tetramethylspiro[1'(2'H)-naphthalene-2(3H)-benzofuran] (1a; K-76), a natural product of fungal origin, and its monocarboxylate sodium salt 1c (R = COONa; K-76COONa) inhibit the classical and alternative pathways of complement, and 1c was shown to inhibit the classical pathway at the C5 activation step. In an attempt to elucidate the essential pharmacophore of 1a,c, the natural product was used as a "topographical model" for the design of partial analogs retaining the desired complement inhibiting potency. Therefore, A/C/D-ring analogs have been synthesized, as shown in Scheme 1 using 3-methoxyphenol (3) and limonene chloride (5) as starting materials, which contain functional groups similar to those found on the natural product. The use of (4R)-(+)- and (4S)(-)-limonene chloride (5a,b, respectively) provided two series of compounds differing in the stereochemistry of the C-4 chiral center (limonene moiety numbering). The in vitro assay results of the inhibition of anaphylatoxin production and classical complement-mediated hemolysis revealed that 7-carboxy-2-(R,S)-methyl-2-(1'-methylcyclohexen-(4'R)-yl)-4-met hoxybenzofuran (13a) and 7-carboxy-2-(R,S)-methyl-2-(1'-methylcyclohexen-(4'S)-yl)-4-met hoxybenzofuran (13b) were active in the same range of concentrations as the natural product.


Subject(s)
Complement Inactivator Proteins/chemical synthesis , Sesquiterpenes/chemical synthesis , Stachybotrys/chemistry , Animals , Cell Division/drug effects , Complement C3a/antagonists & inhibitors , Complement C3a/biosynthesis , Complement C5a/antagonists & inhibitors , Complement C5a/biosynthesis , Complement Inactivator Proteins/pharmacology , Drug Design , Guinea Pigs , Hemolysis/drug effects , Humans , Lymphocytes/drug effects , Mice , Sesquiterpenes/pharmacology
6.
J Med Chem ; 25(7): 858-64, 1982 Jul.
Article in English | MEDLINE | ID: mdl-6125597

ABSTRACT

N-Alkylated derivatives of 2-amino-4,7-dimethoxyindan were prepared for evaluation of central and peripheral dopaminergic activity using biochemical and behavioral tests in the rat and cardiovascular responses in the cat. 2-(Di-n-propylamino)-4,7-dimethoxyindan (4e) demonstrated equal activity with apomorphine to activate peripheral presynaptic dopamine receptors. Central pre- and postsynaptic dopamine receptors were also activated with 4e. In contrast to the intense long-acting sympathomimetic actions previously reported for the 2-amino-5,8-dimethoxytetralins, these compounds produced weak, transient effects in heart rate and blood pressure. The majority of 2-amino-4,7-dimethoxyindan derivatives tested are weak or inactive pre- and postsynaptic dopamine receptor agonists.


Subject(s)
Dopamine/physiology , Hemodynamics/drug effects , Indans/chemical synthesis , Indenes/chemical synthesis , Animals , Binding, Competitive , Cats , Cattle , Central Nervous System/drug effects , Chemical Phenomena , Chemistry , Electric Stimulation , Humans , In Vitro Techniques , Indans/pharmacology , Male , Mice , Motor Activity/drug effects , Neurotransmitter Agents/biosynthesis , Rats , Rats, Inbred Strains , Spiperone/metabolism , Stereotyped Behavior/drug effects
7.
Appl Environ Microbiol ; 38(5): 836-9, 1979 Nov.
Article in English | MEDLINE | ID: mdl-543700

ABSTRACT

Several microorganisms were examined for their abilities to convert S-nicotine into nornicotine. Five microorganisms including Microsporum gypseum (ATCC 11395) produced nornicotine and three unknown metabolites. M. gypseum efficiently reduced nicotine-1'-N-oxide to nicotine, but no nornicotine was obtained when the N-oxide was used as substrate.


Subject(s)
Cyclic N-Oxides/metabolism , Microsporum/metabolism , Nicotine/analogs & derivatives , Nicotine/metabolism , Chemical Phenomena , Chemistry , Fermentation , Fungi/metabolism , Oxidation-Reduction , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...